HC Wainwright Reiterates Buy Rating on Adagene, Keeps $7 Price Target
HC Wainwright reiterated its Buy rating on Adagene and maintained a $7 price target. The target implies 239.8% upside from the October 16 close of $2.06.
HC Wainwright reiterated its Buy rating on Adagene and maintained a $7 price target. The target implies 239.8% upside from the October 16 close of $2.06.